Cancer-related fatigue: A review

Revista da Associacao Medica Brasileira

Volumn 57, Issue 2, 2011, Pages 206-214

  Campos, Maira Paschoin de Oliveira ^a   Hassan, Benjamin Joseph ^b   Riechelmann, Rachel ^c   del Giglio, Auro ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Adjuvant; Chemotherapy; Fatigue; Guarana (homeopathy); Neoplasms

Indexed keywords

EID: 79955735806     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0104-4230(11)70046-x     Document Type: Review

References (98)

1. Gupta D, Lis CG, Grutsch JF. The relationship between cancer-related fatigueand patient satisfiaction with quality of life in cancer. J Pain Symptom Manage. 2007; 34(1):40-7.
2. Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol. 2000; 11(8):971-5.
3. Lis CG, Rodeghier M, Grutsch JF, Gupta D. Distribution and determinants of patient satisfaction in oncology with a focus on health related quality of life. BMC Health Serv Res. 2009; 9:190
4. Mock V, Atkinson A, Barsevick AM, Berger AM, Cimprich B, Eisen-berger MA, et al. Cancer-related fatigue. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2007; 5(10):1054-78. Review.
5. Curt GA, Breitbart W, Cella D, Groopman JE Horning SJ, Itri LM, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 2000; 5(5):353-60.
6. Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol. 1997; 34(3 Suppl 2):4-12.
7. Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S. Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 2003; 98(9):1786-801.
8. Flechtner H, Bottomley A. Fatigue and quality of life: lessons from the real world. Oncologist 2003; 8(Suppl 1):5-9.
9. Wang XS, Giralt SA, Mendoza TR, Engstrom MC, Johnson BA, Peterson N et al. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol. 2002; 20(5):1319-28.
10. Cella D, Davis K, Breitbart W, Curt G; Fatigue Coalition. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001; 19(14):3385-91.
11. Gutstein HB. The biologic basis of fatigue. Cancer 2001; 92(6 Sup-pl):1678-83.
12. Parker K P, Bliwise DL, Ribeiro M, Jain SR, Vena CI, Kohles-Baker MK et al. Sleep/Wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol. 2008; 26(15):2464-72.
13. Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003; 97(11):2919-25.
14. Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res. 2006; 12(9):2759-66.
15. Scott HR, McMillan DC, Forrest LM, Brown DJ, McArdle CS, Milroy R. Te systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 2002; 87(3):264-7.
16. Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky I, Downie F P, Sabate K et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol. 2005; 23(31):8025-32.
17. Lundstrom S, Furst CJ. Symptoms in advanced cancer: relationship to endogenous cortisol levels. Palliat Med. 2003; 17(6):503-8.
18. Scott HR, McMillan DC, Brown DJ, Forrest LM, McArdle CS, Mil-roy R. A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Cancer 2003; 40(3):295-9.
19. Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinfammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002; 64(4):604-11.
20. Bower JE, Ganz PA, Aziz N, Fahey JL, Cole S W. T-cell homeosta-sis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst. 2003; 95(15):1165-8.
21. Levy MR. Cancer fatigue: a neurobiological review for psychiatrists. Psychosomatics 2008; 49(4):283-91. Review.
22. Ryan JL, Carroll JK, Ryan E P, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist 2007; 12(Suppl 1):22-34.
23. Jereczek-Fossa BA, Marsiglia HR, Orecchia R. Radiotherapy-related fatigue. Crit Rev Oncol Hematol. 2002; 41(3):317-25. Review.
24. Malik UR, Makower DF, Wadler S. Interferon-mediated fatigue. Cancer. 2001 Sep 15; 92(6 Suppl):1664-8.
25. Atkins MB, Mier J W, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med. 1988; 318(24):1557-63.
26. Jereczek-Fossa BA, Santoro L, Alterio D, Franchi B, Fiore MR, Fossati P et al. Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients. Int J Radiat Oncol Biol Phys. 2007; 68(2):403-15.
27. Littlewood TJ, Kallich JD, San Miguel J, Hendricks L, Hedenus M. Efficacy of darbepoetin alfa in alleviating fatigue and the effect of fatigue on quality of life in anemic patients with lymphoproliferative malignancies. J Pain Symptom Manage. 2006; 31(4):317-25.
28. Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B et al. National Institutes of Health State-of-the-Science Panel. National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. J Natl Cancer Inst. 2003; 95(15):1110-7. Review.
29. Luthy C, Cedraschi C, Pugliesi A, Di Silvestro K, Mugnier-Konrad B, Rapiti E et al. Patients' views about causes and preferences for the management of cancer-related fatigue-a case for non-congruence with the physicians? Support Care Cancer 2010 Feb 19. [Epub ahead of print]
30. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK et al. Te rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999; 85(5):1186-96.
31. Alexander S, Minton O, Stone PC. Evaluation of screening instruments for cancer-related fatigue syndrome in breast cancer survivors. J Clin Oncol. 2009; 27(8):1197-201.
32. Stein KD, Jacobsen PB, Blanchard CM, Tors C. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage. 2004; 27(1):14-23.
33. Knobel H, Håvard Loge J, Brit Lund M, Forfang K, Nome O, Kaasa S. Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol. 2001; 19(13):3226-33.
34. Escalante C P, Kallen MA, Valdres RU, Morrow PK, Manzullo EF. Outcomes of a cancer-related fatigue clinic in a comprehensive cancer center. J Pain Symptom Manage. 2010; 39(4):691-701.
35. Lotf-Jam K, Carey M, Jeford M, Schofeld P, Charleson C, Aranda S. Nonpharmacologic strategies for managing common chemotherapy adverse Effects: a systematic review. J Clin Oncol. 2008; 26(34):5618-29.
36. Velthuis MJ, Agasi-Idenburg SC, Aufdemkampe G, Wittink HM. Te Effect of physical exercise on cancer-related fatigue during cancer treatment: a meta-analysis of randomised controlled trials. Clin Oncol (R Coll Radiol). 2010; 22(3):208-21.
37. Segal R, Evans W, Johnson D, Smith J, Colletta S, Gayton J et al. Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol. 2001; 19(3):657-65.
38. Torsen L, Skovlund E, Strømme SB, Hornslien K, Dahl AA, Fosså SD. Effectiveness of physical activity on cardiorespiratory ftness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy. J Clin Oncol. 2005; 23(10):2378-88.
39. Dimeo F, Fetscher S, Lange W, Mertelsmann R, Keul J. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood 1997; 90(9):3390-4.
40. Windsor PM, Nicol KF, Potter J. A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 2004; 101(3):550-7.
41. Dimeo F, Schwartz S, Fietz T, Wanjura T, Böning D, Tiel E. Effects of endurance training on the physical performance of patients with hematological malignancies during chemotherapy. Support Care Cancer 2003; 11(10):623-8.
42. Grifth K, Wenzel J, Shang J, Tompson C, Stewart K, Mock V. Impact of a walking intervention on cardiorespiratory fitness, self-reported physical function, and pain in patients undergoing treatment for solid tumors. Cancer 2009; 115(20):4874-84.
43. Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol. 2009; 27(27):4605-12.
44. Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003; 21(9):1660-8.
45. Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999; 85(10):2273-7.
46. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D'Angelo ME, Wells GA. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003; 21(9):1653-9.
47. Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny G P, Prud'Homme DG et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol. 2009; 27(3):344-51.
48. Milne HM, Wallman KE, Gordon S, Courneya KS. Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat. 2008; 108(2):279-88.
49. Adamsen L, Quist M, Andersen C, Møller T, Herrstedt J, Kronborg D et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ. 2009; 339:b3410.
50. Vallance JK, Courneya KS, Plotnikof RC, Yasui Y, Mackey JR. Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors. J Clin Oncol. 2007; 25(17):2352-9.
51. Lucía A, Earnest C, Pérez M. Cancer-related fatigue: can exercise physiology assist oncologists? Lancet Oncol. 2003; 4(10):616-25.
52. Schwartz AL, Mori M, Gao R, Nail LM, King ME. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc. 2001; 33(5):718-23.
53. Duijts SF, Faber MM, Oldenburg HS, van Beurden M, Aaronson NK. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors-a meta-analysis. Psychooncology 2011; 20(2):115-26.
54. Boesen EH, Ross L, Frederiksen K, Tomsen BL, Dahlstrøm K, Schmidt G et al. Psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study. J Clin Oncol. 2005; 23(6):1270-7.
55. Weis J. Support groups for cancer patients. Support Care Cancer. 2003; 11(12):763-8.
56. Trijsburg RW, van Knippenberg FC, Rijpma SE. Effects of psychological treatment on cancer patients: a critical review. Psychosom Med. 1992; 54(4):489-517.
57. Luebbert K, Dahme B, Hasenbring M. Te Effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology 2001; 10(6):490-502.
58. Jacobsen PB, Meade CD, Stein KD, Chirikos TN, Small BJ, Ruck-deschel JC. Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol. 2002; 20(12):2851-62.
59. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendo-crinology 2004; 29(4):448-74.
60. Decker T W, Cline-Elsen J, Gallagher M. Relaxation therapy as an adjunct in radiation oncology. J Clin Psychol. 1992; 48(3):388-93.
61. Given C, Given B, Rahbar M, Jeon S, McCorkle R, Cimprich B et al. Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. J Clin Oncol. 2004; 22(3):507-16.
62. Gaston-Johansson F, Fall-Dickson JM, Nanda J, Ohly KV, Stillman S, Krumm S et al. Te Effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation. Cancer Nurs. 2000; 23(4):277-85.
63. Gielissen MF, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol. 2006; 24(30):4882-7.
64. Stanton AL, Ganz PA, Kwan L, Meyerowitz BE, Bower JE, Krupnick JL et al. Outcomes from the moving beyond cancer psychoeduca-tional, randomized, controlled trial with breast cancer patients. J Clin Oncol. 2005; 23(25):6009-18.
65. Yates P, Aranda S, Hargraves M, Mirolo B, Clavarino A, McLachlan S et al. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2005; 23(25):6027-36.
66. Ream E, Richardson A, Alexander-Dann C. Supportive intervention for fatigue in patients undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manage. 2006; 31(2):148-61.
67. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev. 2009; (1):CD006953. Review.
68. Barsevick AM, Dudley W, Beck S, Sweeney C, Whitmer K, Nail L. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer 2004; 100(6):1302-10.
69. Simeit R, Deck R, Conta-Marx B. Sleep management training for cancer patients with insomnia. Support Care Cancer 2004; 12(3):176-83.
70. Berger AM, Von Essen S, Khun BR, Piper BF, Farr L, Agrawal S, et al. Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 2002; 29(10):1431-41.
71. Berger AM, Kuhn BR, Farr LA, Von Essen SG, Chamberlain J, Lynch JC et al. One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J Clin Oncol. 2009; 27(35):6033-40.
72. Melchart D, Ihbe-Hefnger A, Leps B, von Schilling C, Linde K. Acupuncture and acupressure for the prevention of chemotherapy-induced nausea--a randomized cross-over pilot study. Support Care Cancer 2006; 14(8):878-82.
73. Mock V, Atkinson A, Barsevick AM, Berger AM, Cimprich B, Eisen-berger MA et al. NCCN Clinical Practice Guidelines in Oncology: cancer-related fatigue, v.1. 2006. [cited 2011 jan 28]. Jenkintown: National Comprehensive Cancer Network; 2006. Available from: http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf.
74. Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol. 2003; 21(23):4439-43.
75. Sarhill N, Walsh D, Nelson KA, Homsi J, LeGrand S, Davis M P. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care 2001; 18(3):187-92.
76. Schwartz AL, Tompson JA, Masood N. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum. 2002; 29(7):E85-90.
77. Sugawara Y, Akechi T, Shima Y, Okuyama T, Akizuki N, Nakano T et al. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study. Palliat Med. 2002; 16(3):261-3.
78. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998; 16(7):2522-7.
79. Bruera E, Chadwick S, Brenneis C, Hanson J, MacDonald RN. Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep. 1987; 71(1):67-70.
80. Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2006; 24(13):2073-8.
81. Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z et al. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manage. 2009; 38(5):650-62.
82. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst. 2008; 100(16):1155-66. Review.
83. Morrow GR, Roscoe JA, Heckler CE, Schwartzenberger PO, Giguere JK, Dakhil SR. A phase III randomized, placebo-controlled, double-blind trial of a eugeroic agent in 642 cancer patients reporting fatigue during chemotherapy: A URCC CCOP Study. 2008 [cited 2010 April 24]. J Clin Oncol 2008; 26:504s. Available from: http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=55&abstractID=35609.
84. Spathis A, Dhillan R, Booden D, Forbes K, Vrotsou K, Fife K. Modafinil for the treatment of fatigue in lung cancer: a pilot study. Palliat Med. 2009; 23(4):325-31.
85. Blackhall L, Petroni G, Shu J, Baum L, Farace E. A pilot study evaluating the safety and efficacy of modafnal for cancer-related fatigue. J Palliat Med. 2009; 12(5):433-9.
86. Rizzo JD, Somerfeld MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL et al. American Society of Clinical Oncology; American Society of Hematology. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol. 2008; 26(1):132-49. Erratum in: J Clin Oncol. 2008; 26(7):1192.
87. Seidenfeld J, Piper M, Flamm C, Hasselblad V, Armitage JO, Bennett CL et al. Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. J Natl Cancer Inst. 2001; 93(16):1204-14.
88. Ross SD, Allen IE, Henry DH, Seaman C, Sercus B, Goodnough LT. Clinical benefts and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature. Clin Ter. 2006; 28(6):801-31. Review. Erratum in: Clin Ter. 2007; 29(5):985-6.
89. Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J et al. Erythropoietin or darbepoetin for patients with cancer. Co-chrane Database Syst Rev. 2006; 3:CD003407.
90. Haskell CF, Kennedy DO, Wesnes KA, Milne AL, Scholey AB. A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural Effects of guarana in humans. J Psychopharmacol. 2007; 21(1):65-70.
91. Heckman MA, Weil J, Gonzalez de Mejia E. Cafeine (1, 3, 7-trimeth-ylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci. 2010; 75(3):R77-87. Review.
92. Campos M P, Martins RRLC, Hassan BJ, Casa FB, Del Giglio A. ABC Medical School, Santo André, Brazil; Jackson Memorial Hospital, Miami, FL; Força Vital Pharmacy, Sao Paulo, Brazil; ABC Foundation School of Medicine, Santo André, Brazil. Effect of guarana (Paullinia cupana) on fatigue in breast cancer patients undergoing systemic chemotherapy. Citation: J Clin Oncol. 2010; 28(Suppl):7s. (abstr 9007, ASCO Annual Meeting).
93. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep. 1985 Jul-Aug; 69(7-8):751-4. PubMed PMID: 2410117.
94. Bruera E, El Osta B, Valero V, Driver LC, Pei BL, Shen L et al. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2007; 25(23):3475-81.
95. Auret KA, Schug SA, Bremner AP, Bulsara M. A randomized double-blind, placebo-controlled trial assessing the impact of dexampheta-mine on fatigue in patients with advanced cancer. J Pain Symptom Manage. 2009; 37(4):613-21.
96. Souza Fêde AB, Bensi CG, Trufelli DC, Oliveira Campos M P, Pec-oroni PG, Ranzatti RP et al. Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trial. Am J Clin Oncol. 2007; 30(4):432-6.
97. Morrow GR, Hickok JT, Roscoe JA, Raubertas RF, Andrews PL, Flynn PJ et al. University of Rochester Cancer Center Community Clinical Oncology Program. Diferential Effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003; 21(24):4635-41
98. Stockler MR, O'Connell R, Nowak AK, Goldstein D, Turner J, Wilcken NR et al. Zolof's Effects on Symptoms and survival Time Trial Group. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol. 2007; 8(7):603-12. E ratum in: Lancet Oncol. 2007; 8(7):574.